Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
4.200
+0.040 (0.96%)
May 29, 2025, 2:45 PM CST
SHA:600488 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 133.49 | 133.45 | 117.05 | 35.41 | 48.67 | 33.98 | Upgrade
|
Depreciation & Amortization | 289.28 | 289.28 | 271.09 | 257.07 | 205.27 | 183.75 | Upgrade
|
Other Amortization | 7.56 | 7.56 | 1.82 | 0.15 | 4.04 | 0.51 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | -0.65 | 0.94 | 0.02 | 0.18 | Upgrade
|
Asset Writedown & Restructuring Costs | 45.67 | 45.67 | 51.42 | 136.53 | 56.26 | 0.03 | Upgrade
|
Loss (Gain) From Sale of Investments | 9.09 | 9.09 | 1.13 | 22.44 | -4.99 | 1.22 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | -0.02 | 0.02 | -0.26 | -0.17 | Upgrade
|
Other Operating Activities | -9.54 | 52.55 | 21.43 | -35.94 | 55.56 | 135.18 | Upgrade
|
Change in Accounts Receivable | 77.31 | 77.31 | -163.08 | 87.75 | -210.34 | -257.56 | Upgrade
|
Change in Inventory | 95 | 95 | 431.73 | -194.44 | 126.07 | 216.04 | Upgrade
|
Change in Accounts Payable | -152.15 | -152.15 | 52.22 | 351.63 | 34.88 | 30.21 | Upgrade
|
Operating Cash Flow | 507.32 | 569.37 | 783.01 | 653.52 | 316.89 | 346.88 | Upgrade
|
Operating Cash Flow Growth | -22.19% | -27.28% | 19.81% | 106.23% | -8.65% | 8.51% | Upgrade
|
Capital Expenditures | -64.82 | -77.74 | -133.15 | -202.2 | -370.84 | -458.51 | Upgrade
|
Sale of Property, Plant & Equipment | 1.95 | 1.95 | 1.03 | 4.07 | 0.68 | 0.39 | Upgrade
|
Cash Acquisitions | - | - | - | - | -10.17 | -140.03 | Upgrade
|
Divestitures | -0.4 | -0.4 | - | - | - | - | Upgrade
|
Other Investing Activities | 0.4 | - | - | - | 3.37 | 14 | Upgrade
|
Investing Cash Flow | -62.87 | -76.19 | -132.12 | -198.13 | -376.96 | -584.14 | Upgrade
|
Short-Term Debt Issued | - | - | - | 155 | 175 | 233.05 | Upgrade
|
Long-Term Debt Issued | - | 780.49 | 580.5 | 1,098 | 1,527 | 2,065 | Upgrade
|
Total Debt Issued | 896.61 | 780.49 | 580.5 | 1,253 | 1,702 | 2,298 | Upgrade
|
Short-Term Debt Repaid | - | - | -77 | -30 | -303.05 | -58 | Upgrade
|
Long-Term Debt Repaid | - | -1,199 | -995.57 | -1,185 | -1,229 | -1,978 | Upgrade
|
Total Debt Repaid | -1,148 | -1,199 | -1,073 | -1,215 | -1,532 | -2,036 | Upgrade
|
Net Debt Issued (Repaid) | -251.75 | -418.37 | -492.07 | 38.09 | 169.23 | 261.63 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 20.56 | Upgrade
|
Repurchase of Common Stock | -4.77 | -4.77 | -5.78 | -8.69 | -1.74 | -0 | Upgrade
|
Common Dividends Paid | -120.16 | -123.37 | -47.75 | -60.26 | -58.22 | -81.05 | Upgrade
|
Other Financing Activities | -74.02 | -71 | -19.25 | -23.71 | -16.58 | -26.76 | Upgrade
|
Financing Cash Flow | -450.7 | -617.52 | -564.85 | -54.57 | 92.69 | 174.37 | Upgrade
|
Foreign Exchange Rate Adjustments | 10.76 | 15.89 | 8.17 | 0.59 | 1.33 | -2.43 | Upgrade
|
Net Cash Flow | 4.52 | -108.44 | 94.2 | 401.41 | 33.95 | -65.32 | Upgrade
|
Free Cash Flow | 442.5 | 491.63 | 649.86 | 451.33 | -53.95 | -111.63 | Upgrade
|
Free Cash Flow Growth | -15.28% | -24.35% | 43.99% | - | - | - | Upgrade
|
Free Cash Flow Margin | 14.10% | 15.29% | 17.18% | 12.23% | -1.44% | -3.58% | Upgrade
|
Free Cash Flow Per Share | 0.40 | 0.45 | 0.59 | 0.41 | -0.05 | -0.10 | Upgrade
|
Cash Interest Paid | - | - | - | 4.83 | 0.92 | 5.62 | Upgrade
|
Cash Income Tax Paid | 134.66 | 139.86 | 194.44 | 167.01 | 147.23 | 131.61 | Upgrade
|
Levered Free Cash Flow | 338.86 | 433.66 | 480.9 | 427.86 | -78.42 | 35.8 | Upgrade
|
Unlevered Free Cash Flow | 354.8 | 451.67 | 503.82 | 457.96 | -49.73 | 60.92 | Upgrade
|
Change in Net Working Capital | 37.73 | -63.58 | -253.33 | -289.58 | -0.44 | -223.91 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.